Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to evaluate and describe the surgical and overall outcomes of subjects who undergo pancreatectomy and hepatic resection/ablation for pancreatic cancer with low-volume hepatic metastases, as part of routine care. Subjects will be followed to determine operative risks and 90-day morbidity and mortality. In addition, survival outcomes will be compared to historical controls who did not undergo surgery. Secondary outcomes will include mortality and morbidity; operative time; blood loss and transfusion requirements; and oncologic outcomes such as: margin status, lymph node harvest, disease-free survival, and overall survival. Analysis of subject and tumor characteristics will help the investigator identify subjects who would benefit from this aggressive multimodal approach.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02892305
Study type Observational
Source Duke University
Contact Diana Stephenson
Phone 919-613-5798
Email diana.stephenson@duke.edu
Status Not yet recruiting
Phase N/A
Start date April 1, 2018
Completion date August 2021

See also
  Status Clinical Trial Phase
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Not yet recruiting NCT03175146 - A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely N/A
Recruiting NCT02571530 - Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer Phase 1
Recruiting NCT02395224 - A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway N/A
Completed NCT02374411 - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients N/A
Recruiting NCT01960829 - Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study Phase 2
Terminated NCT01846429 - Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain Phase 1
Completed NCT01933789 - Improving Communication About Serious Illness N/A
Recruiting NCT01564810 - Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer Phase 4
Completed NCT00375245 - Rapamycin With Grapefruit Juice for Advanced Malignancies Phase 1
Completed NCT00232726 - Clinical Study of Previously Untreated Patients With Malignant Melanoma Phase 2
Completed NCT00207116 - An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma Phase 1
Completed NCT00172003 - Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis Phase 4
Completed NCT00207103 - MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors Phase 1
Completed NCT00094003 - Study of NS-9 in Patients With Liver Metastases Phase 1
Completed NCT00029900 - ADI-PEG in Patients With Metastatic Melanoma Phase 1
Completed NCT00001835 - Oxaliplatin in Cancer Patients With Impaired Kidney Function Phase 1
Completed NCT00289445 - Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) Phase 1/Phase 2
Completed NCT00001587 - A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver Phase 1
Completed NCT00001302 - A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 Phase 1